vs

Side-by-side financial comparison of MetLife (MET) and VISHAY INTERTECHNOLOGY INC (VSH). Click either name above to swap in a different company.

MetLife is the larger business by last-quarter revenue ($19.1B vs $800.9M, roughly 23.8× VISHAY INTERTECHNOLOGY INC). MetLife runs the higher net margin — 6.0% vs 0.1%, a 5.9% gap on every dollar of revenue. On growth, VISHAY INTERTECHNOLOGY INC posted the faster year-over-year revenue change (12.1% vs 2.7%). Over the past eight quarters, MetLife's revenue compounded faster (484.7% CAGR vs 3.6%).

MetLife, Inc. is the holding corporation for the Metropolitan Life Insurance Company (MLIC), better known as MetLife, and its affiliates. MetLife is among the largest global providers of insurance, annuities, and employee benefit programs, with around 90 million customers in over 60 countries. The firm was founded on March 24, 1868. MetLife ranked No. 43 in the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Vishay Intertechnology, Inc. is an American manufacturer of discrete semiconductors and passive electronic components founded by Polish-born businessman Felix Zandman. Vishay has manufacturing plants in Israel, Asia, Europe, and the Americas where it produces rectifiers, diodes, MOSFETs, optoelectronics, selected integrated circuits, resistors, capacitors, and inductors. Vishay Intertechnology revenues for 2024 were $2.9 billion. At the end of 2024, Vishay had approximately 22,700 full-time e...

MET vs VSH — Head-to-Head

Bigger by revenue
MET
MET
23.8× larger
MET
$19.1B
$800.9M
VSH
Growing faster (revenue YoY)
VSH
VSH
+9.3% gap
VSH
12.1%
2.7%
MET
Higher net margin
MET
MET
5.9% more per $
MET
6.0%
0.1%
VSH
Faster 2-yr revenue CAGR
MET
MET
Annualised
MET
484.7%
3.6%
VSH

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
MET
MET
VSH
VSH
Revenue
$19.1B
$800.9M
Net Profit
$1.1B
$986.0K
Gross Margin
19.6%
Operating Margin
1.8%
Net Margin
6.0%
0.1%
Revenue YoY
2.7%
12.1%
Net Profit YoY
30.0%
101.5%
EPS (diluted)
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MET
MET
VSH
VSH
Q1 26
$19.1B
Q4 25
$600.0M
$800.9M
Q3 25
$621.0M
$790.6M
Q2 25
$604.0M
$762.3M
Q1 25
$611.0M
$715.2M
Q4 24
$556.0M
$714.7M
Q3 24
$554.0M
$735.4M
Q2 24
$558.0M
$741.2M
Net Profit
MET
MET
VSH
VSH
Q1 26
$1.1B
Q4 25
$809.0M
$986.0K
Q3 25
$896.0M
$-7.9M
Q2 25
$729.0M
$2.0M
Q1 25
$945.0M
$-4.1M
Q4 24
$1.3B
$-66.1M
Q3 24
$1.3B
$-19.3M
Q2 24
$946.0M
$23.5M
Gross Margin
MET
MET
VSH
VSH
Q1 26
Q4 25
19.6%
Q3 25
19.5%
Q2 25
19.5%
Q1 25
19.0%
Q4 24
19.9%
Q3 24
20.5%
Q2 24
22.0%
Operating Margin
MET
MET
VSH
VSH
Q1 26
Q4 25
1.8%
Q3 25
2.4%
Q2 25
2.9%
Q1 25
0.1%
Q4 24
-7.9%
Q3 24
-2.5%
Q2 24
5.1%
Net Margin
MET
MET
VSH
VSH
Q1 26
6.0%
Q4 25
134.8%
0.1%
Q3 25
144.3%
-1.0%
Q2 25
120.7%
0.3%
Q1 25
154.7%
-0.6%
Q4 24
228.6%
-9.2%
Q3 24
242.2%
-2.6%
Q2 24
169.5%
3.2%
EPS (diluted)
MET
MET
VSH
VSH
Q1 26
Q4 25
$1.18
$0.01
Q3 25
$1.22
$-0.06
Q2 25
$1.03
$0.01
Q1 25
$1.28
$-0.03
Q4 24
$1.75
$-0.48
Q3 24
$1.81
$-0.14
Q2 24
$1.28
$0.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MET
MET
VSH
VSH
Cash + ST InvestmentsLiquidity on hand
$515.0M
Total DebtLower is stronger
$14.8B
$950.9M
Stockholders' EquityBook value
$27.6B
$2.1B
Total Assets
$743.2B
$4.2B
Debt / EquityLower = less leverage
0.54×
0.46×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MET
MET
VSH
VSH
Q1 26
Q4 25
$25.6B
$515.0M
Q3 25
$26.2B
$443.9M
Q2 25
$27.5B
$473.9M
Q1 25
$26.9B
$609.4M
Q4 24
$25.2B
$590.3M
Q3 24
$26.4B
$643.8M
Q2 24
$24.6B
$672.7M
Total Debt
MET
MET
VSH
VSH
Q1 26
$14.8B
Q4 25
$950.9M
Q3 25
$919.7M
Q2 25
$914.5M
Q1 25
$988.2M
Q4 24
$905.0M
Q3 24
$820.8M
Q2 24
$820.6M
Stockholders' Equity
MET
MET
VSH
VSH
Q1 26
$27.6B
Q4 25
$28.4B
$2.1B
Q3 25
$28.9B
$2.1B
Q2 25
$27.7B
$2.1B
Q1 25
$27.5B
$2.0B
Q4 24
$27.4B
$2.0B
Q3 24
$30.9B
$2.2B
Q2 24
$27.3B
$2.2B
Total Assets
MET
MET
VSH
VSH
Q1 26
$743.2B
Q4 25
$745.2B
$4.2B
Q3 25
$719.7B
$4.2B
Q2 25
$702.5B
$4.2B
Q1 25
$688.3B
$4.2B
Q4 24
$677.5B
$4.1B
Q3 24
$705.0B
$4.2B
Q2 24
$675.7B
$4.2B
Debt / Equity
MET
MET
VSH
VSH
Q1 26
0.54×
Q4 25
0.46×
Q3 25
0.44×
Q2 25
0.44×
Q1 25
0.49×
Q4 24
0.45×
Q3 24
0.38×
Q2 24
0.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MET
MET
VSH
VSH
Operating Cash FlowLast quarter
$149.4M
Free Cash FlowOCF − Capex
$54.6M
FCF MarginFCF / Revenue
6.8%
Capex IntensityCapex / Revenue
11.8%
Cash ConversionOCF / Net Profit
151.48×
TTM Free Cash FlowTrailing 4 quarters
$-89.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MET
MET
VSH
VSH
Q1 26
Q4 25
$7.1B
$149.4M
Q3 25
$3.6B
$27.6M
Q2 25
$2.2B
$-8.8M
Q1 25
$4.3B
$16.1M
Q4 24
$4.6B
$67.7M
Q3 24
$4.2B
$50.6M
Q2 24
$3.5B
$-24.7M
Free Cash Flow
MET
MET
VSH
VSH
Q1 26
Q4 25
$54.6M
Q3 25
$-24.7M
Q2 25
$-73.4M
Q1 25
$-45.5M
Q4 24
$-77.2M
Q3 24
$-9.0M
Q2 24
$-87.3M
FCF Margin
MET
MET
VSH
VSH
Q1 26
Q4 25
6.8%
Q3 25
-3.1%
Q2 25
-9.6%
Q1 25
-6.4%
Q4 24
-10.8%
Q3 24
-1.2%
Q2 24
-11.8%
Capex Intensity
MET
MET
VSH
VSH
Q1 26
Q4 25
11.8%
Q3 25
6.6%
Q2 25
8.5%
Q1 25
8.6%
Q4 24
20.3%
Q3 24
8.1%
Q2 24
8.4%
Cash Conversion
MET
MET
VSH
VSH
Q1 26
Q4 25
8.75×
151.48×
Q3 25
3.98×
Q2 25
3.00×
-4.39×
Q1 25
4.51×
Q4 24
3.63×
Q3 24
3.11×
Q2 24
3.69×
-1.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MET
MET

Premiums, fees and other revenues$14.3B75%
Other$4.8B25%

VSH
VSH

Resistors Segment$189.4M24%
Diodes Segment$154.2M19%
Capacitors Segment$136.5M17%
Other$126.4M16%
Inductors Segment$92.6M12%
Optoelectronic Components Segment$55.7M7%
EMS Companies$51.6M6%

Related Comparisons